Industry Focus Transcripts

The company is using RFID and artificial intelligence to monitor inventory.

The retailer has dwindling cash and a dwindling customer base.

The chain is in real financial trouble.

What Novartis' misstep means to investors, plus how Exact Sciences is trying to lock up the genetic testing market.

Kevin Bennett chats about the business of refi, company culture, the startup world and more.

Frequently called the MercadoLibre of Africa, Jumia has some huge opportunities ahead of it.

Is it a sign of progress, or could there be more trouble ahead?

And how is the company going to fund its near-term growth?

The retailer may well be too far gone to save, and its ill-defined turnaround plan won’t change that.

The streaming platform powerhouse's earnings were negative, but still surprisingly good.

Here’s a fintech company and a small bank on our radar.

Let’s take a step back and put it into perspective.

Square is down more than 20% since issuing its second-quarter earnings. Here’s what investors should know.

A bull and a bear walk into a room and (civilly!) talk about the most controversial stock on the market.

These three companies are pumping fresh air into the lungs of millions all over the world.

A new IPO just entered our orbit, but do the risks of the unknown outweigh the potential for interstellar margins?

Here’s an interview with the head of one of our favorite fintechs and the other financial-sector news you need to know.

Education producer 2U’s entire business model has to change, and the market doesn’t like it.

HEXO could run into some legal troubles soon, and short sellers are eagerly awaiting a drop.

Long-term investors should probably stay away from Beyond Meat until/unless the stock drops substantially from here.